A Study to Evaluate the Efficacy and Safety of AD-208
Sponsored by Addpharma Inc.
About this trial
Last updated 2 years ago
Study ID
AD-208P3
Status
Completed
Type
Interventional
Phase
Phase 3
Placebo
No
Accepting
18 to 50 Years
Male
Not accepting
Healthy Volunteers
Trial Timing
Ended 2 years ago
What is this trial about?
The purpose of this study is to evaluate the efficacy and safety of AD-208.
What are the participation requirements?
Inclusion Criteria
- Male patients aged 18-50 years, inclusive
- Patients who meet the appropriate criteria according to the classification of hair loss
- Signed informed consent
Exclusion Criteria
- Patients with hair loss disorders other than androgenetic alopecia
- Other exclusions applied